XML 44 R30.htm IDEA: XBRL DOCUMENT v3.25.1
Segment Data (Tables)
 3 Months Ended
Mar. 29, 2025
Segment Data [Abstract]  
Business Segment Information
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Three Months Ended
March 29,
March 30,
2025
2024
Gross Sales:
Global Distribution and Value
 
-Added Services
(1)
$
2,676
$
2,693
Global Specialty Products
(2)
367
360
Global Technology
(3)
162
157
Total Gross Sales
3,205
3,210
Less: Eliminations:
Global Distribution and Value
 
-Added Services
 
(4)
(8)
Global Specialty Products
(33)
(30)
Total eliminations
(37)
(38)
Net Sales
Global Distribution and Value
 
-Added Services
 
2,672
2,685
Global Specialty Products
 
334
330
Global Technology
162
157
Total Net Sales
$
3,168
$
3,172
Three Months Ended
March 29,
March 30,
2025
2024
Operating Income
Global Distribution and Value
 
-Added Services
$
167
$
171
Global Specialty Products
56
43
Global Technology
42
34
Total Segment Operating Income
265
248
Corporate
(35)
(22)
Adjustments
(4)
(55)
(76)
Total Operating Income
$
175
$
150
Depreciation and Amortization
Global Distribution and Value
 
-Added Services
$
35
$
36
Global Specialty Products
27
25
Global Technology
11
12
Total Depreciation and Amortization
$
73
$
73
Global Distribution and Value
 
-Added Services: Includes distribution of infection-control products, handpieces, preventatives,
impression materials, composites, anesthetics, teeth, gypsum, acrylics, articulators, abrasives, personal protective equipment
(“PPE”) products,
 
branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, dental chairs, delivery units
and lights, digital dental laboratories, X-ray supplies and equipment, high-tech and digital restoration equipment, equipment repair
services, financial services on a non-recourse basis, continuing education services for practitioners, consulting and other services.
 
This segment also markets and sells under our own corporate brand, a portfolio of cost-effective, high-quality consumable
merchandise.
(2)
Global Specialty Products: Includes manufacturing, marketing and sales of dental implant and biomaterial products; and
endodontic, orthodontic and orthopedic products and other health care-related products and services.
(3)
Global Technology: Includes development and distribution of practice management software, e-services, and other products, which
are distributed to health care providers.
Adjustments represent items excluded from segment operating income to enable comparison of financial results between periods.
 
The following table presents a breakdown of such adjustments:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Three Months Ended
March 29,
March 30,
2025
2024
Adjustments:
Restructuring costs
$
(25)
$
(10)
Acquisition intangible amortization
(43)
(46)
Cyber incident-third-party advisory expenses, net of insurance
20
(5)
Changes in contingent consideration
2
(15)
Impairment of intangible assets
(1)
-
Costs associated with shareholder advisory matters
(8)
-
Total adjustments
$
(55)
$
(76)